Vergleich

Mouse Anti-Human Type I Collagen

ArtNr 20-787-275147
Hersteller GENWAY
Menge 0.1 mg
Kategorie
Typ Antibody
Applikationen IHC
Clon 4F6
Specific against Human (Homo sapiens)
Host Mouse
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-4902AE
Similar products 20-787-275147
Lieferbar
Genway ID:
GWB-4902AE
Isotype:
Mouse IgG2b
Clone:
4F6
Characterization:
To insure lot-to-lot consistency each batch of product is tested to conform to characteristics of a standard reference reagent using SDS-PAGE analysis and immunohistochemistry.
Specificity:
Reacts with Human Type I Collagen. Cross reactivity with other species has not been established.
Working Dilution:

Immunohistochemistry: 2 ug/mL
Function:
Type I collagen is a member of group I collagen (fibrillar forming collagen).
Subunit:
Trimers of one alpha 2(I) and two alpha 1(I) chains.
Subcellular Location:
Secreted extracellular space extracellular matrix (By similarity).
Tissue Specificity:
Forms the fibrils of tendon ligaments and bones. In bones the fibrils are mineralized with calcium hydroxyapatite.
Ptm:
Prolines at the third position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some or all of the chains.
Disease:
Defects in COL1A2 are the cause of Ehlers-Danlos syndrome type VII-B (EDS-VII-B) [MIM:130060]; an autosomal dominant connective-tissue disorder characterized by arthrochalasis multiplex congenita and skin hyperextensibility and bruisability.
Disease:
Defects in COL1A2 are a cause of osteogenesis imperfecta type I (OI-I) [MIM:166200]. OI-I is a dominantly inherited serious newborn disease characterized by bone fragility normal stature little or no deformity blue sclerae and hearing loss in 50% of families. Dentinogenesis imperfecta is rare and may distinguish a subset of OI type I (formation of dentine).
Disease:
Defects in COL1A2 are a cause of osteogenesis imperfecta type II (OI-II) [MIM:166210]; also known as osteogenesis imperfecta congenita (OIC) or lethal perinatal. OI-II is a serious newborn disease that diffusely affects bone. Infants are born with multiple fractures which lead to shortening of the extremities. The skull is soft and resembles a \" bag of bones\" when palpated the sclera are abnormally thin and may appear blue and some infants also have a hearing loss. Infants born alive often die suddenly during the first few days or weeks of life but a few survive as deformed dwarfs. Mental development is normal unless head trauma with CNS injury occurs. There is no effective treatment.
Disease:
Defects in COL1A2 are the cause of cardiac valvular form of autosomal recessive Ehlers-Danlos syndrome (cardiac valvular EDS) [MIM:225320]; also known as arthrochalasis type Ehlers-Danlos syndrome. In addition to joint laxity skin hyperextensibility and friability and abnormal scar formation individuals with this form of EDS appear to be at increased risk for cardiac valvular dysfunction.
Disease:
Defects in COL1A2 are a cause of osteogenesis imperfecta type III (OI-III) [MIM:259420]. OI-III usually presents with moderate deformity at birth progressively deforming bones and sclerae variable in color. Dentinogenesis imperfecta and hearing loss are common. Stature is very short.
Disease:
Defects in COL1A2 are a cause of osteogenesis imperfecta type IV (OI-IV) [MIM:166220]; also known as osteogenesis imperfecta with normal sclerae. OI-IV presents with moderate to mild deformity and variable short stature. Dentinogenesis imperfecta is common and hearing loss occurs in some.
Disease:
A chromosomal rearrangement involving COL1A2 may be a cause of lipoblastomas which are benign tumors resulting from transformation of adipocytes usually diagnosed in children. Translocation t(7; 8)(p22; q13) with PLAG1.
Similarity:
Belongs to the fibrillar collagen family. [1] Makela J. K. Vuorio T. and Vuorio E. et al. Growth-dependent modulation of type I collagen production and mRNA levels in cultured human skin fibroblasts[2] de Wet W. J. Bernard M. P. Benson-Chanda V. Chu M. -L. Dickson L. A. Weil D. Ramirez F. Organization of the human pro-alpha 2(I) collagen gene. [3] Dalgleish R. The human type I collagen mutation database. [4] Korkko J. M. Ala-Kokko L. De Paepe A. Nuytinck L. Earley J. J. Prockop D. J. Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: identification of common sequences of null-allele mutations. [5] Kuivaniemi H. Tromp G. Chu M. -L. Prockop D. J. Structure of a full-length cDNA clone for the prepro alpha 2(I) chain of human type I procollagen. Comparison with the chicken gene confirms unusual patterns of gene conservation. [6] Dickson L. A. de Wet W. Di Liberto M. Weil D. Ramirez F. Analysis of the promoter region and the N-propeptide domain of the human pro alpha 2(I) collagen gene. [7] Akai J. Kimura A. Arai K. Uehara K. Hata R. Fine structural analysis of the unique 5\' region of the human COL1A2 gene containing two regions of dinucleotide repeats adjacent to the transcriptional start site. [8] Weil D. D\' Alessio M. Ramirez F. Eyre D. R. Structural and functional characterization of a splicing mutation in the pro-alpha 2(I) collagen gene of an Ehlers-Danlos type VII patient. [9] Watson R. B. Wallis G. A. Holmes D. F. Viljoen D. Byers P. H. Kadler K. E. Ehlers Danlos syndrome type VIIB. Incomplete cleavage of abnormal type I procollagen by N-proteinase in vitro results in the formation of copolymers of collagen and partially cleaved pNcollagen that are near circular in cross-section. [10] Click E. M. Bornstein P. Isolation and characterization of the cyanogen bromide peptides from the alpha 1 and alpha 2 chains of human skin collagen.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 0.1 mg
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen